PKA-mediated responses in females' estrous cycle affect cocaine-induced responses in dopamine-mediated intracellular cascades

Neuroscience

Volumn 161, Issue 3, 2009, Pages 865-876

  Weiner, J ^b   Sun, W Lun ^b   Zhou, L ^b   Kreiter, C M ^a   Jenab, S ^a,b   Quinones Jenab V ^a,b  

^a CITY UNIVERSITY OF NEW YORK   (United States)

^b CITY UNIVERSITY OF NEW YORK   (United States)

Author keywords

cocaine; CREB; DARPP; estrous cycle; females; PKA

Indexed keywords

COCAINE; CYCLIC AMP DEPENDENT PROTEIN KINASE; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; DOPAMINE; PHOSPHOPROTEIN DARPP 32; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ARTICLE; CAUDATE NUCLEUS; ESTRUS CYCLE; FEMALE; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; RAT;

ANIMALS; BLOTTING, WESTERN; CAUDATE NUCLEUS; COCAINE; CYCLIC AMP RESPONSE ELEMENT-BINDING PROTEIN; CYCLIC AMP-DEPENDENT PROTEIN KINASES; DOPAMINE; DOPAMINE AND CAMP-REGULATED PHOSPHOPROTEIN 32; DOPAMINE UPTAKE INHIBITORS; ESTROUS CYCLE; FEMALE; NUCLEUS ACCUMBENS; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-FOS; PUTAMEN; RATS; RATS, INBRED F344; RECEPTORS, NEUROPEPTIDE Y; SIGNAL TRANSDUCTION; TIME FACTORS;

EID: 67349189433     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2009.03.071     Document Type: Article

References (75)

1. Becker J.B. Direct effect of 17b-estradiol on striatum: sex differences in dopamine release. Synapse 5 (1990) 157-164
2. Becker J.B. Gender differences in dopaminergic function in striatum and nucleus accumbens. Pharmacol Biochem Behav 64 (1999) 803-812
3. Becker J.B., and Cha J. Estrous cycle-dependent variation in amphetamine-induced behaviors and striatal dopamine release assessed with microdialysis. Behav Brain Res 35 (1989) 117-125
4. Becker J.B., Monteggia L., Perrot-Sinal T., Romeo R.D., Taylor J.R., Yehuda R., and Bale T. Stress and disease: is being female a predisposing factor?. J Neurosci 27 (2007) 11851-11855
5. Becker J.B., Robinson T.E., and Lorenz K. Sex differences and estrous cycle variations in amphetamine-elicited rotational behavior. Eur J Pharmacol 80 (1982) 65-72
6. Bibb J.A., Chen J., Taylor J.R., Svenningsson P., Nishi A., Snyder G.L., Yan Z., Sagawa Z.K., Ouimet C.C., Nairn A.C., Nestler E.J., and Greengard P. Effects of chronic exposure to cocaine are regulated by the neuronal protein Cdk5. Nature 410 (2001) 376-380
7. Borgkvist A., and Fisone G. Psychoactive drugs and regulation of the cAMP/PKA/DARPP-32 cascade in striatal medium spiny neurons. Neurosci Biobehav Rev 31 (2007) 79-88
8. Carlezon W.A.J., Thome J., Olson V.G., Lane-Ladd S.B., Brodkin E.S., Hiroi N., Duman R.S., Neve R.L., and Nestler E.J. Regulation of cocaine reward by CREB. Science 282 (1998) 2272-2275
9. Chin J., Sternin O., Wu H.B.K., Burrell S., Lu D., Jenab S., Perrotti L.I., and Quiñones-Jenab V. Endogenous gonadal hormones modulate behavioral and neurochemical responses to acute and chronic cocaine administration. Brain Res 945 (2002) 123-130
10. Colby C.R., Whisler K., Steffen C., Nestler E.J., and Self D.W. FosB enhances incentive for cocaine. J Neurosci 23 (2003) 2488-2493
11. Deutch A.Y., Tam S.Y., and Roth R.H. Footshock and conditioned stress increase 3,4-dihydroxyphenylacetic acid (DOPAC) in the ventral tegmental area but not substantia nigra. Brain Res 616 (1985) 89-98
12. Di Paolo T., Poyet P., and Labrie F. Effects of prolactin and estradiol on rat striatal dopamine receptors. Life Sci 31 (1982) 2921-2929
13. Evans S.M., Haney M., and Foltin R.W. The effects of smoked cocaine during the follicular and luteal phases of the menstrual cycle in women. Psychopharmacology 159 (2002) 397-406
14. Fader A.J., Argolias A., Melis M.R., Tissari A.H., Onali P.L., and Gessa G.L. Stress induced increase in 3.4 dihydroxyphenylacetic acid (DOPAC) levels in the cerebral cortex and in the nucleus accumbens: reversal by diazepam. Life Sci 23 (1978) 2219-2224
15. Festa E.D., Russo S.J., Gazi F.M., Niyomchai T., Kemen L.M., Lin S.-N., Foltz R., Jenab S., and Quiñones-Jenab V. Sex differences in cocaine-induced behavioral responses, pharmacokinetics, and monoamine levels. Neuropharmacology 46 (2004) 672-687
16. Fienberg A.A., Hiroi N., Mermelstein P.G., Song W., Snyder G.L., Nishi A., Cheramy A., O'Callaghan J.P., Miller D.B., Cole D.G., Corbett D., Haile C.N., Cooper D.C., Onn S.P., Grace A.A., Ouimet C.C., White F.J., Hyman S.E., Surmeier D.J., Girault J., Nestler E.J., and Greengard P. DARPP-32: regulator of the efficacy of dopaminergic neurotransmission. Science 281 (1998) 838-841
17. Freeman M.E. The neuroendocrine control of the ovarian cycle of the rat. In: Knobil E., and Neill J.D. (Eds). The physiology of reproduction (1994), Raven Press, Ltd, New York 613-658
18. Graybiel A.M., Moratalla R., and Robertson H.A. Amphetamine and cocaine induce drug-specific activation of the c-Fos gene in striosome-matrix compartments and limbic subdivisions of the striatum. Proc Natl Acad Sci U S A 87 (1990) 6912-6916
19. Greengard P., Allen P.B., and Nairn A.C. Beyond the dopamine receptor: the DARPP-32/protein phosphatase-1 cascade. Neuron 23 (1999) 435-447
20. Hiroi N., Brown J., Haile C., Ye H., Greenberg M., and Nestler E. Fos B mutant mice: loss of chronic cocaine induction of fos related proteins and heightened sensitivity to cocaine's psychomotor and rewarding effects. Proc Natl Acad Sci U S A 94 (1997) 10397-10402
21. Hu X.T., Ford K., and White F.J. Repeated cocaine administration decreases calcineurin (PP2B) but enhances DARPP-32 modulation of sodium currents in rat nucleus accumbens neurons. Neuropsychopharmacology 30 (2005) 916-926
22. Hyman S.E., Malenka R.C., and Nestler E.J. Neural mechanisms of addiction: the role of reward-related learning and memory. Annu Rev Neurosci 29 (2006) 565-598
23. Hyman S.E., and Malenka R.C. Addiction and the brain: the neurobiology of compulsion and its persistence. Nat Rev Neurosci 2 (2001) 695-703
24. Jenab S., Festa E.D., Nazarian A., Wu H.B., Sun W.L., Hazim R., Russo S.J., and Quiñones-Jenab V. Cocaine induction of ERK proteins in dorsal striatum of Fischer rats. Brain Res Mol Brain Res 142 (2005) 134-138
25. Jones S., and Bonci A. Synaptic plasticity and drug addiction. Curr Opin Pharmacol 5 (2005) 20-25
26. Jori A., and Cecchetti G. Homovanillic acid levels in rat striatum during the oestrous cycle. J Endocrinol 58 (1973) 341-342
27. Joyce J.N., and Van Hartesveldy C. Estradiol application to the striatum produces postural deviation to systemic apomorphine. Pharmacol Biochem Behav 20 (1984) 575-581
28. Kelz M.B., Chen J.S., Carlezon W.A., Whisler K., Gilden L., Beckmann A.M., Steffen C., Zhang Y., Marotti L., Self D.W., Tkatch R., Baranauskas G., Surmeier D.J., Neve R.L., Duman R.S., Picciotto M.R., and Nestler E.J. Expression of the transcription factor ΔFosB in the brain controls the sensitivity to cocaine. Nature 401 (1999) 272-276
29. Kelz M.B., and Nestler E.J. ΔFosB: a molecular switch underlying long-term neural plasticity. Curr Opin Neurol 13 (2000) 715-720
30. Kosten T.A., Gawin F.H., Kosten T.R., and Rounsaville B.J. Gender differences in cocaine use and treatment response. J Substance Abuse Treat 10 (1993) 63-66
31. Kosten T.R., Kosten T.A., McDougle C.J., Hameedi F.A., McCance E.F., Rosen M.I., Oliveto A.H., and Price L.H. Gender differences in response to intranasal cocaine administration to humans. Biol Psychiatry 39 (1996) 147-148
32. Levesque D., and Di Paolo D.T. Rapid conversion of high into low striatal D2-dopamine receptor agonist binding states after an acute physiological dose of 17 beta-estradiol. Neurosci Lett 88 (1988) 113-118
33. 1 dopamine receptor density fluctuates during the rat estrous cycle. Neurosci Lett 98 (1989) 345-350
34. Lynch W.J., Kiraly D.D., Caldarone B.J., Picciotto M.R., and Taylor J.R. Effect of cocaine self-administration on striatal PKA-regulated signaling in male and female rats. Psychopharmacology 191 (2007) 263-271
35. Lynch W.J., Roth M.E., and Carroll M.E. Biological basis of sex differences in drug abuse: preclinical and clinical studies. Psychopharmacology 164 (2002) 121-137
36. Machado B.H., and Brody M.J. Mechanisms of pressor response produced by stimulation of nucleus ambiguus. Am J Physiol 259 (1990) R955-R962
37. Mayr B., and Montminy M. Transcriptional regulation by the phosphorylation-dependent factor CREB. Nat Rev Mol Cell Biol 2 (2001) 588-609
38. Miserendino M.J., and Nestler E.J. Behavioral sensitization to cocaine: modulation by the cyclic AMP system in the nucleus accumbens. Brain Res 674 (1995) 299-306
39. Nazarian A., Wu H.B.K., Sun W.L., Kemen L.M., Jenab S., and Quiñones-Jenab V. Sex differences in basal and cocaine-induced alterations in PKA protein levels in the nucleus accumbens. Psychopharmacology 203 (2009) 641-650
40. Nestler E.J., Barrot M., and Self D.W. ΔFosB: a molecular switch for addiction. Proc Natl Acad Sci U S A 98 (2001) 11042-11046
41. Nestler E.J., Hyman S.E., and Malenka R.C. Molecular basis of neuropharmacology (2001), McGraw-Hill, New York
42. Nestler E.J., and Malenka R.C. The addicted brain. Sci Am 290 (2004) 78-85
43. Nishi A., Bibb J.A., Snyder G.L., Higashi H., Nairn A.C., and Greengard P. Amplification of dopaminergic signaling by a positive feedback loop. Proc Natl Acad Sci U S A 97 (2000) 12840-12845
44. Pani L., Porcella A., and Gessa G.L. The role of stress in the pathophysiology of the dopaminergic system. Mol Psychiatry 5 (2000) 14-21
45. Pierce R.C., and Kalivas P.W. A circuitry model of the expression of behavioral sensitization to amphetamine-like psychostimulants. Brain Res 25 (1997) 192-216
46. Pliakas A.M., Carlson R.R., Neve R.L., Konradi C., Nestler E.J., and Carlezon W.A.J. Altered responsiveness to cocaine and increased immobility in the forced swim test associated with elevated cAMP response element-binding protein expression in nucleus accumbens. J Neurosci 21 (2001) 7397-7403
47. Quiñones-Jenab V., Ho A., Schlussman S.D., Franck J., and Kreek M.J. Estrous cycle differences in cocaine-induced stereotypic and locomotor behaviors in Fischer rats. Behav Brain Res 101 (1999) 15-20
48. Rauggi R., Scheggi S., Cassanelli A., De Montis M.G., Tagliamonte A., and Gambarana C. The mesolimbic dopaminergic response to novel palatable food consumption increases dopamine-D1 receptor-mediated signaling with complex modifications of the DARPP-32 phosphorylation pattern. J Neurochem 92 (2005) 867-877
49. Robbins S.J., Ehrman R.N., Chidress A.R., and O'Brian C.P. Comparing levels of cocaine cue reactivity in male and female outpatients. Drug Alcohol Depend 53 (1999) 223-230
50. Robinson T.E., Camp D.M., Jacknow D.S., and Becker J.B. Sex differences and estrous cycle dependent variation in rotational behavior elicited by electrical stimulation of the mesostriatal dopamine system. Behav Brain Res 6 (1982) 273-287
51. Roth M.E., Cosgrove K.P., and Carroll M.E. Sex differences in the vulnerability to drug abuse: a review of preclinical studies. Neurol Biobehav Rev 28 (2004) 533-546
52. Russo S.J., Jenab S., Fabian S.J., Festa E.D., Kemen L.M., and Quiñones-Jenab V. Sex differences in the conditioned rewarding effects of cocaine. Brain Res 970 (2003) 214-220
53. Self D.W., Genova L.M., Hope B.T., Barnhart W.J., Spencer J.J., and Nestler E.J. Involvement of cAMP-dependent protein kinase in the nucleus accumbens in cocaine self-administration and relapse of cocaine-seeking behavior. J Neurosci 18 (1998) 1848-1859
54. Sell S.L., Scalzitti J.M., Thomas M.L., and Cunningham K.A. Influence of ovarian hormones and estrous cycle on the behavioral response to cocaine in female rats. J Pharmacol Exp Ther 293 (2000) 879-886
55. Shaywitz A.J., and Greenberg M.E. CREB: a stimulus-induced transcription factor activated by a diverse array of extracellular signals. Annu Rev Biochem 68 (1999) 821-861
56. Sofuoglu M., Duidish-Poulsen S., Nelson D., Pentel P.R., and Hatsukami D.K. Sex and menstrual cycle differences in the subjective effects from smoked cocaine in humans. Exp Clin Psychopharmacol 7 (1999) 274-283
57. Sun W., Zhou L., Hazim R., Quiñones-Jenab V., and Jenab S. Effects of acute cocaine on ERK and DARPP-32 phosphorylation pathways in the caudate-putamen of Fischer rats. Brain Res 1178 (2007) 9-12
58. Svenningsson P., Nairn A.C., and Greengard P. DARPP-32 mediates the actions of multiple drugs of abuse. AAPS J 7 (2005) E353-E360
59. Thierry A.M., Tassin J.P., Blanc G., and Glowinski J. Selective activation of the mesocortical DA system by stress. Nature 263 (1976) 242-243
60. Valjent E., Pascoli V., Svenningsson P., Paul S., Herve E., Corvol J.C., Stipanovich A., Caboche J., Lombroso P.J., Nairn A.C., Greengard P., Herve D., and Girault J.A. Regulation of a protein phosphatase cascade allows convergent dopamine and glutamate signals to activate ERK in the striatum. Proc Natl Acad Sci U S A 102 (2005) 491-496
61. Van Etten M.L., and Anthony J.C. Comparative epidemiology of initial drug opportunities and transitions to first use: marijuana, cocaine hallucinogens and heroin. Addiction 54 (1999) 117-125
62. Van Etten M.L., and Anthony J.C. Male-female differences in transitions from first drug opportunity to first use: searching for subgroup variation by age, race, region, and urban status. J Womens Health Gend Based Med 8 (2001) 797-804
63. Van Etten M.L., Neumark Y.D., and Anthony J.C. Male-female differences in the earliest stages of drug involvement. Addiction 94 (1999) 1413-1419
64. Van Haaren F., and Meyer M.E. Sex differences in locomotor activity after acute and chronic cocaine administration. Pharmacol Biochem Behav 39 (1991) 923-927
65. Walker Q.D., Cabassa J., Hilmar A.S., and Kuhn C.M. Sex differences in cocaine-stimulated motor behavior: disparate effects of gonadectomy. Neuropsychopharmacology 25 (2001) 118-130
66. Walker Q.D., Frances R., Cabbassa J., and Kuhn C.M. Effect of ovarian hormones and estrous cycle on stimulation of the hypothalamo-pituitary-adrenal axis by cocaine. J Pharmacol Exp Ther 297 (2001) 291-298
67. Walters C.L., and Blendy J.A. Different requirements for cAMP response element binding protein in positive and negative reinforcing properties of drugs of abuse. J Neurosci 21 (2001) 9438-9444
68. Wolf M.E., Mangiavacchi S., and Sun X. Mechanisms by which dopamine receptors may influence synaptic plasticity. Ann N Y Acad Sci 1003 (2003) 241-249
69. Xiao L., and Becker J.B. Quantitative microdialysis determination of extracellular striatal dopamine concentration in male and female rats: effects of estrous cycle and gonadectomy. Neurosci Lett 180 (1994) 155-158
70. Yoshida M., and Precht W. Monosynaptic inhibition of neurons of the substantia nigra by caudato-nigral fibers. Brain Res 32 (1971) 225-228
71. Young S.T., Porrino L.J., and Iadarola M.J. Cocaine induces striatal c-fos immunoreactive proteins via dopaminergic D1 receptors. Proc Natl Acad Sci U S A 88 (1991) 1291-1295
72. Zachariou V., Benoit-Marand M., Allen P.B., Ingrassia P., Fienberg A.A., Gonon F., Greengard P., and Picciotto M.R. Reduction of cocaine place preference in mice lacking the protein phosphatase 1 inhibitors DARPP 32 or inhibitor 1. Biol Psychiatry 51 (2002) 612-620
73. Zachariou V., Berton O., Perrotti L.I., and Nestler E.J. FosB in the nucleus accumbens modulates morphine reward, tolerance, and dependence. Soc Neurosci Abstr 29 (2003) 112
74. Zachariou V., Sgambato-Faure V., Sasaki T., Svenningsson P., Berton O., Fienberg A.A., Nairn A.C., Greengard P., and Nestler E.J. Phosphorylation of DARPP-32 at threonine-34 is required for cocaine action. Neuropsychopharmacology 31 (2006) 555-562
75. Zhou L., Nazarian A., Sun W.L., Jenab S., and Quiñones-Jenab V. Basal and cocaine-induced sex differences in DARPP-32-mediated signaling pathway. Psychopharmacology 203 (2009) 175-183